Literature DB >> 16159985

Harnessing the preconditioning phenomenon: does remote organ ischaemia provide the answer?

A Burdess, D Newby.   

Abstract

Despite progress in defining the cellular mechanisms of the ischaemic preconditioning phenomenon, its conversion into convenient clinical practice has been slow. The possibility that an innate mechanism of tissue resistance to ischaemia could be harnessed as a clinical tool is an attractive and enticing prospect.

Entities:  

Mesh：

Year:  2005        PMID： 16159985      PMCID： PMC1861060          DOI： 10.1136/hrt.2005.064931

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


  16 in total

Review 1.  Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality?

Authors:  D M Yellon; G F Baxter
Journal:  Heart       Date:  2000-04       Impact factor: 5.994

2.  Remote preconditioning.

Authors:  Gerd Heusch; Rainer Schulz
Journal:  J Mol Cell Cardiol       Date:  2002-10       Impact factor: 5.000

Review 3.  Ischaemic preconditioning protects against ischaemia/reperfusion injury: emerging concepts.

Authors:  S Pasupathy; S Homer-Vanniasinkam
Journal:  Eur J Vasc Endovasc Surg       Date:  2005-02       Impact factor: 7.069

4.  Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial.

Authors:  K W Mahaffey; J A Puma; N A Barbagelata; M F DiCarli; M A Leesar; K F Browne; P R Eisenberg; R Bolli; A C Casas; V Molina-Viamonte; C Orlandi; R Blevins; R J Gibbons; R M Califf; C B Granger
Journal:  J Am Coll Cardiol       Date:  1999-11-15       Impact factor: 24.094

5.  Preconditioning the human myocardium.

Authors:  D M Yellon; A M Alkhulaifi; W B Pugsley
Journal:  Lancet       Date:  1993-07-31       Impact factor: 79.321

6.  Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revascularization.

Authors:  D J Patel; H J Purcell; K M Fox
Journal:  Eur Heart J       Date:  1999-01       Impact factor: 29.983

7.  Protection against acute porcine lung ischemia/reperfusion injury by systemic preconditioning via hind limb ischemia.

Authors:  Thomas Waldow; Konstantin Alexiou; Wolfgang Witt; Steffen Albrecht; Florian Wagner; Michael Knaut; Klaus Matschke
Journal:  Transpl Int       Date:  2005-02       Impact factor: 3.782

8.  Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.

Authors:  F Tomai; F Crea; A Gaspardone; F Versaci; R De Paulis; A Penta de Peppo; L Chiariello; P A Gioffrè
Journal:  Circulation       Date:  1994-08       Impact factor: 29.690

9.  [Clinical research of ischemic preconditioning on lung protection].

Authors:  S Chen; G Li; L Long
Journal:  Hunan Yi Ke Da Xue Xue Bao       Date:  1999

10.  Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischaemia.

Authors:  J S Ikonomidis; L C Tumiati; R D Weisel; D A Mickle; R K Li
Journal:  Cardiovasc Res       Date:  1994-08       Impact factor: 10.787
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.